Medagate Turns OTC Purchases Into Data For Manufacturers, Insurers
This article was originally published in The Tan Sheet
Executive Summary
Medagate Corp. says its “restricted-spend platform” can help OTC manufacturers boost sales and insurance providers reduce their customers’ health care costs and provide both groups with a window into additional data about consumers’ spending habits.
You may also be interested in...
Supreme Court Routes OTC Health Savings Battle Back To Congress
The future of the provision requiring prescriptions for OTC purchases with health savings accounts is back in Congress’ hands. But with elections pending, lawmakers will likely stay away from legislation that would change, rather than repeal, the ACA.
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.
FDA Details “Quality Agreements” For Marketers, Contract Manufacturers
The “Contract Manufacturing Arrangements for Drugs: Quality Agreements” draft guidance describes how parties involved in contract manufacturing of drugs can employ quality agreements to delineate their responsibilities and ensure drug quality, safety and efficacy.